{
    "nct_id": "NCT06317220",
    "official_title": "Vedolizumab for the Treatment of Collagenous Gastritis",
    "inclusion_criteria": "* Age 14 or older\n* Weight of at least 40kg\n* Has a biopsy-confirmed diagnosis of collagenous gastritis\n* Agrees to all required study procedures\n* Presence of one or more collagenous gastritis symptom at a severity of Grade 1 or higher at the time of enrollment: abdominal pain, nausea, diarrhea, bloating, vomiting, flatulence, constipation, fatigue, headache, rash\nHealthy volunteers allowed\nMust have minimum age of 14 Years",
    "exclusion_criteria": "* Unable to independently provide informed consent or assent\n* Allergic to vedolizumab or any of its components",
    "miscellaneous_criteria": ""
}